Report cover image

Global TACE Embolic Microspheres Market Analysis and Forecast 2025-2031

Publisher APO Research, Inc.
Published Jul 08, 2025
Length 191 Pages
SKU # APRC20282774

Description

Summary

According to APO Research, The global TACE Embolic Microspheres market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for TACE Embolic Microspheres is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for TACE Embolic Microspheres is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for TACE Embolic Microspheres is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for TACE Embolic Microspheres is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of TACE Embolic Microspheres include ABK Biomedical, Boston Scientific, Merit Medical, Mermaid Medical, Sirtex Medical, Terumo, Varian, Cardiolink Science and Suzhou Hengrui Medical Equipment, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for TACE Embolic Microspheres, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of TACE Embolic Microspheres, also provides the sales of main regions and countries. Of the upcoming market potential for TACE Embolic Microspheres, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the TACE Embolic Microspheres sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global TACE Embolic Microspheres market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for TACE Embolic Microspheres sales, projected growth trends, production technology, application and end-user industry.

TACE Embolic Microspheres Segment by Company

ABK Biomedical
Boston Scientific
Merit Medical
Mermaid Medical
Sirtex Medical
Terumo
Varian
Cardiolink Science
Suzhou Hengrui Medical Equipment
TACE Embolic Microspheres Segment by Type

Common Embolic Microspheres
Drug-Loadable Embolic Microspheres
TACE Embolic Microspheres Segment by Application

Colorectal Cancer Liver Metastasis
Primary Liver Cancer
Others
TACE Embolic Microspheres Segment by Region

North America

United States
Canada
Mexico
Europe

Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific

China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America

Brazil
Argentina
Chile
Middle East & Africa

Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global TACE Embolic Microspheres market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of TACE Embolic Microspheres and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of TACE Embolic Microspheres.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of TACE Embolic Microspheres in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of TACE Embolic Microspheres manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, TACE Embolic Microspheres sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

191 Pages
1 Market Overview
1.1 Product Definition
1.2 TACE Embolic Microspheres Market by Type
1.2.1 Global TACE Embolic Microspheres Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Common Embolic Microspheres
1.2.3 Drug-Loadable Embolic Microspheres
1.3 TACE Embolic Microspheres Market by Application
1.3.1 Global TACE Embolic Microspheres Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Colorectal Cancer Liver Metastasis
1.3.3 Primary Liver Cancer
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 TACE Embolic Microspheres Market Dynamics
2.1 TACE Embolic Microspheres Industry Trends
2.2 TACE Embolic Microspheres Industry Drivers
2.3 TACE Embolic Microspheres Industry Opportunities and Challenges
2.4 TACE Embolic Microspheres Industry Restraints
3 Global Market Growth Prospects
3.1 Global TACE Embolic Microspheres Revenue Estimates and Forecasts (2020-2031)
3.2 Global TACE Embolic Microspheres Revenue by Region
3.2.1 Global TACE Embolic Microspheres Revenue by Region: 2020 VS 2024 VS 2031
3.2.2 Global TACE Embolic Microspheres Revenue by Region (2020-2025)
3.2.3 Global TACE Embolic Microspheres Revenue by Region (2026-2031)
3.2.4 Global TACE Embolic Microspheres Revenue Market Share by Region (2020-2031)
3.3 Global TACE Embolic Microspheres Sales Estimates and Forecasts 2020-2031
3.4 Global TACE Embolic Microspheres Sales by Region
3.4.1 Global TACE Embolic Microspheres Sales by Region: 2020 VS 2024 VS 2031
3.4.2 Global TACE Embolic Microspheres Sales by Region (2020-2025)
3.4.3 Global TACE Embolic Microspheres Sales by Region (2026-2031)
3.4.4 Global TACE Embolic Microspheres Sales Market Share by Region (2020-2031)
3.5 US & Canada & Mexico
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
4.1 Global TACE Embolic Microspheres Revenue by Manufacturers
4.1.1 Global TACE Embolic Microspheres Revenue by Manufacturers (2020-2025)
4.1.2 Global TACE Embolic Microspheres Revenue Market Share by Manufacturers (2020-2025)
4.1.3 Global TACE Embolic Microspheres Manufacturers Revenue Share Top 10 and Top 5 in 2024
4.2 Global TACE Embolic Microspheres Sales by Manufacturers
4.2.1 Global TACE Embolic Microspheres Sales by Manufacturers (2020-2025)
4.2.2 Global TACE Embolic Microspheres Sales Market Share by Manufacturers (2020-2025)
4.2.3 Global TACE Embolic Microspheres Manufacturers Sales Share Top 10 and Top 5 in 2024
4.3 Global TACE Embolic Microspheres Sales Price by Manufacturers (2020-2025)
4.4 Global TACE Embolic Microspheres Key Manufacturers Ranking, 2023 VS 2024 VS 2025
4.5 Global TACE Embolic Microspheres Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global TACE Embolic Microspheres Manufacturers, Product Type & Application
4.7 Global TACE Embolic Microspheres Manufacturers' Establishment Date
4.8 Market Competitive Analysis
4.8.1 Global TACE Embolic Microspheres Market CR5 and HHI
4.8.2 2024 TACE Embolic Microspheres Tier 1, Tier 2, and Tier 3
5 TACE Embolic Microspheres Market by Type
5.1 Global TACE Embolic Microspheres Revenue by Type
5.1.1 Global TACE Embolic Microspheres Revenue by Type (2020 VS 2024 VS 2031)
5.1.2 Global TACE Embolic Microspheres Revenue by Type (2020-2031) & (US$ Million)
5.1.3 Global TACE Embolic Microspheres Revenue Market Share by Type (2020-2031)
5.2 Global TACE Embolic Microspheres Sales by Type
5.2.1 Global TACE Embolic Microspheres Sales by Type (2020 VS 2024 VS 2031)
5.2.2 Global TACE Embolic Microspheres Sales by Type (2020-2031) & (K Units)
5.2.3 Global TACE Embolic Microspheres Sales Market Share by Type (2020-2031)
5.3 Global TACE Embolic Microspheres Price by Type
6 TACE Embolic Microspheres Market by Application
6.1 Global TACE Embolic Microspheres Revenue by Application
6.1.1 Global TACE Embolic Microspheres Revenue by Application (2020 VS 2024 VS 2031)
6.1.2 Global TACE Embolic Microspheres Revenue by Application (2020-2031) & (US$ Million)
6.1.3 Global TACE Embolic Microspheres Revenue Market Share by Application (2020-2031)
6.2 Global TACE Embolic Microspheres Sales by Application
6.2.1 Global TACE Embolic Microspheres Sales by Application (2020 VS 2024 VS 2031)
6.2.2 Global TACE Embolic Microspheres Sales by Application (2020-2031) & (K Units)
6.2.3 Global TACE Embolic Microspheres Sales Market Share by Application (2020-2031)
6.3 Global TACE Embolic Microspheres Price by Application
7 Company Profiles
7.1 ABK Biomedical
7.1.1 ABK Biomedical Comapny Information
7.1.2 ABK Biomedical Business Overview
7.1.3 ABK Biomedical TACE Embolic Microspheres Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 ABK Biomedical TACE Embolic Microspheres Product Portfolio
7.1.5 ABK Biomedical Recent Developments
7.2 Boston Scientific
7.2.1 Boston Scientific Comapny Information
7.2.2 Boston Scientific Business Overview
7.2.3 Boston Scientific TACE Embolic Microspheres Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Boston Scientific TACE Embolic Microspheres Product Portfolio
7.2.5 Boston Scientific Recent Developments
7.3 Merit Medical
7.3.1 Merit Medical Comapny Information
7.3.2 Merit Medical Business Overview
7.3.3 Merit Medical TACE Embolic Microspheres Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Merit Medical TACE Embolic Microspheres Product Portfolio
7.3.5 Merit Medical Recent Developments
7.4 Mermaid Medical
7.4.1 Mermaid Medical Comapny Information
7.4.2 Mermaid Medical Business Overview
7.4.3 Mermaid Medical TACE Embolic Microspheres Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Mermaid Medical TACE Embolic Microspheres Product Portfolio
7.4.5 Mermaid Medical Recent Developments
7.5 Sirtex Medical
7.5.1 Sirtex Medical Comapny Information
7.5.2 Sirtex Medical Business Overview
7.5.3 Sirtex Medical TACE Embolic Microspheres Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Sirtex Medical TACE Embolic Microspheres Product Portfolio
7.5.5 Sirtex Medical Recent Developments
7.6 Terumo
7.6.1 Terumo Comapny Information
7.6.2 Terumo Business Overview
7.6.3 Terumo TACE Embolic Microspheres Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Terumo TACE Embolic Microspheres Product Portfolio
7.6.5 Terumo Recent Developments
7.7 Varian
7.7.1 Varian Comapny Information
7.7.2 Varian Business Overview
7.7.3 Varian TACE Embolic Microspheres Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Varian TACE Embolic Microspheres Product Portfolio
7.7.5 Varian Recent Developments
7.8 Cardiolink Science
7.8.1 Cardiolink Science Comapny Information
7.8.2 Cardiolink Science Business Overview
7.8.3 Cardiolink Science TACE Embolic Microspheres Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Cardiolink Science TACE Embolic Microspheres Product Portfolio
7.8.5 Cardiolink Science Recent Developments
7.9 Suzhou Hengrui Medical Equipment
7.9.1 Suzhou Hengrui Medical Equipment Comapny Information
7.9.2 Suzhou Hengrui Medical Equipment Business Overview
7.9.3 Suzhou Hengrui Medical Equipment TACE Embolic Microspheres Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Suzhou Hengrui Medical Equipment TACE Embolic Microspheres Product Portfolio
7.9.5 Suzhou Hengrui Medical Equipment Recent Developments
8 North America
8.1 North America TACE Embolic Microspheres Market Size by Type
8.1.1 North America TACE Embolic Microspheres Revenue by Type (2020-2031)
8.1.2 North America TACE Embolic Microspheres Sales by Type (2020-2031)
8.1.3 North America TACE Embolic Microspheres Price by Type (2020-2031)
8.2 North America TACE Embolic Microspheres Market Size by Application
8.2.1 North America TACE Embolic Microspheres Revenue by Application (2020-2031)
8.2.2 North America TACE Embolic Microspheres Sales by Application (2020-2031)
8.2.3 North America TACE Embolic Microspheres Price by Application (2020-2031)
8.3 North America TACE Embolic Microspheres Market Size by Country
8.3.1 North America TACE Embolic Microspheres Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
8.3.2 North America TACE Embolic Microspheres Sales by Country (2020 VS 2024 VS 2031)
8.3.3 North America TACE Embolic Microspheres Price by Country (2020-2031)
8.3.4 United States
8.3.5 Canada
8.3.6 Mexico
9 Europe
9.1 Europe TACE Embolic Microspheres Market Size by Type
9.1.1 Europe TACE Embolic Microspheres Revenue by Type (2020-2031)
9.1.2 Europe TACE Embolic Microspheres Sales by Type (2020-2031)
9.1.3 Europe TACE Embolic Microspheres Price by Type (2020-2031)
9.2 Europe TACE Embolic Microspheres Market Size by Application
9.2.1 Europe TACE Embolic Microspheres Revenue by Application (2020-2031)
9.2.2 Europe TACE Embolic Microspheres Sales by Application (2020-2031)
9.2.3 Europe TACE Embolic Microspheres Price by Application (2020-2031)
9.3 Europe TACE Embolic Microspheres Market Size by Country
9.3.1 Europe TACE Embolic Microspheres Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
9.3.2 Europe TACE Embolic Microspheres Sales by Country (2020 VS 2024 VS 2031)
9.3.3 Europe TACE Embolic Microspheres Price by Country (2020-2031)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
9.3.9 Spain
9.3.10 Netherlands
10 China
10.1 China TACE Embolic Microspheres Market Size by Type
10.1.1 China TACE Embolic Microspheres Revenue by Type (2020-2031)
10.1.2 China TACE Embolic Microspheres Sales by Type (2020-2031)
10.1.3 China TACE Embolic Microspheres Price by Type (2020-2031)
10.2 China TACE Embolic Microspheres Market Size by Application
10.2.1 China TACE Embolic Microspheres Revenue by Application (2020-2031)
10.2.2 China TACE Embolic Microspheres Sales by Application (2020-2031)
10.2.3 China TACE Embolic Microspheres Price by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia TACE Embolic Microspheres Market Size by Type
11.1.1 Asia TACE Embolic Microspheres Revenue by Type (2020-2031)
11.1.2 Asia TACE Embolic Microspheres Sales by Type (2020-2031)
11.1.3 Asia TACE Embolic Microspheres Price by Type (2020-2031)
11.2 Asia TACE Embolic Microspheres Market Size by Application
11.2.1 Asia TACE Embolic Microspheres Revenue by Application (2020-2031)
11.2.2 Asia TACE Embolic Microspheres Sales by Application (2020-2031)
11.2.3 Asia TACE Embolic Microspheres Price by Application (2020-2031)
11.3 Asia TACE Embolic Microspheres Market Size by Country
11.3.1 Asia TACE Embolic Microspheres Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
11.3.2 Asia TACE Embolic Microspheres Sales by Country (2020 VS 2024 VS 2031)
11.3.3 Asia TACE Embolic Microspheres Price by Country (2020-2031)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 Taiwan
11.3.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA TACE Embolic Microspheres Market Size by Type
12.1.1 SAMEA TACE Embolic Microspheres Revenue by Type (2020-2031)
12.1.2 SAMEA TACE Embolic Microspheres Sales by Type (2020-2031)
12.1.3 SAMEA TACE Embolic Microspheres Price by Type (2020-2031)
12.2 SAMEA TACE Embolic Microspheres Market Size by Application
12.2.1 SAMEA TACE Embolic Microspheres Revenue by Application (2020-2031)
12.2.2 SAMEA TACE Embolic Microspheres Sales by Application (2020-2031)
12.2.3 SAMEA TACE Embolic Microspheres Price by Application (2020-2031)
12.3 SAMEA TACE Embolic Microspheres Market Size by Country
12.3.1 SAMEA TACE Embolic Microspheres Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
12.3.2 SAMEA TACE Embolic Microspheres Sales by Country (2020 VS 2024 VS 2031)
12.3.3 SAMEA TACE Embolic Microspheres Price by Country (2020-2031)
12.3.4 Brazil
12.3.5 Argentina
12.3.6 Chile
12.3.7 Colombia
12.3.8 Peru
12.3.9 Saudi Arabia
12.3.10 Israel
12.3.11 UAE
12.3.12 Turkey
12.3.13 Iran
12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
13.1 TACE Embolic Microspheres Value Chain Analysis
13.1.1 TACE Embolic Microspheres Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 TACE Embolic Microspheres Production Mode & Process
13.2 TACE Embolic Microspheres Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 TACE Embolic Microspheres Distributors
13.2.3 TACE Embolic Microspheres Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.